WASHINGTON, D.C.—The American Institute for Medical and Biological Engineering (AIMBE) held its first 2012 Congressional Briefing this past Monday, April 9, 2012 entitled How Translational Research is Transforming Patient Care and the American Economy. The briefing, held on Capitol Hill in the Rayburn building, drew congressional staffers, representatives from AIMBE’s Council of Societies, and other interested individuals.
WASHINGTON, D.C.—Thomas C. Skalak, past-president of the American Institute for Medical and Biological Engineering (AIMBE) and Vice President for Research at the University of Virginia, provided oral and written testimony to the U.S. House Subcommittee on Commerce, Justice, Science, and Related Agencies under the U.S. House Committee on Appropriations concerning the FY 2013 Budget Request and how its priorities set the stage for vital funding of research leading to American innovation.
By Rebecca Adams, CQ Healthbeat Associate Editor Congress must renew a law to allow the Food and Drug Administration to continue approving life-saving drugs and devices. But this renewal has already attracted a myriad of amendments unrelated to the user fees that lawmakers are being asked to approve. The FDA relies on user fees from [...]